Status | Study |
Enrolling by invitation |
Study Name: Screening of Gonococcal and Chlamydial Infections in the Third Trimester Condition: Gonococcal Infection Chlamydia Infections Date: 2017-02-15 |
Recruiting |
Study Name: Prevention of Diseases Induced by Chlamydia Trachomatis Condition: Genital Chlamydia Trachomatis Infection Date: 2016-09-14 Interventions: Other: Testing for Ct infection immediately |
Recruiting |
Study Name: Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years Condition: Chlamydia Trachomatis Date: 2016-05-23 Interventions: Biological: CTH522-CAF01 CTH52 |
Recruiting |
Study Name: Transmission of Genital and Extra-genital Chlamydia Trachomatis Infections in Women Condition: Chlamydia Trachomatis Infection Date: 2016-02-15 Interventions: Other: Chlamydia care as usual |
Terminated |
Study Name: Mecillinam for Treatment of Genital Chlamydia Infection Condition: Chlamydia Trachomatis Infection Chlamydial Urethritis Date: 2014-03-05 Interventions: Drug: Pivmecillinamhydrochlorid PO 400 mg x3 for 7 days |
Enrolling by invitation |
Study Name: Detection of Chlamydia (CT) and Gonorrhea (NG) Condition: Chlamydia Gonorrhea Date: 2014-01-31 Interventions: Device: illumigene CT and NG assays, illumipro-10 |
Completed |
Study Name: Treatment of Antenatal Chlamydia Infection Condition: Chlamydia Trachomatis Infection in Pregnancy Date: 2013-09-16 Interventions: Drug: Amoxicillin Drug: Erythromycin |
Completed |
Study Name: Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women Condition: Chlamydia Trachomatis Infection Date: 2012-06-18 Interventions: Drug: Rifalazil 25 milligram S |
Completed |
Study Name: Home-sampling in Partner Notification of Chlamydia Condition: Chlamydia Date: 2012-05-09 Interventions: Behavioral: Contact tracing mode test at clinic |
Completed |
Study Name: Incubation Time and Test of Cure of Chlamydia Trachomatis Condition: Chlamydia Trachomatis Infection Date: 2011-10-04 |